Associated Papers
An explainable model of host genetic interactions linked to COVID-19 severity.
Onoja A et al.
Communications Biology, 2022
36289370 (PubMed )
Supplement: 42003_2022_4073_MOESM4_ESM.xlsx › S1
Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing.
Aboul-Soud MAM et al.
Saudi Journal of Biological Sciences, 2021
33424349 (PubMed )
Supplement: mmc1.xlsx › Sheet1
Targeted next generation sequencing as a tool for precision medicine.
Gulilat M et al.
Bmc Medical Genomics, 2019
31159795 (PubMed )
Supplement: 12920_2019_527_MOESM1_ESM.xlsx › Table_S6
Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium.
Yee SW et al.
Clinical Pharmacology and Therapeutics, 2018
Identification and functional characterization of novel nonsynonymous variants in the human multidrug and toxin extrusion 2-K.
Nishimura K et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2014
A gene-gene interaction between polymorphisms in the OCT2 and MATE1 genes influences the renal clearance of metformin.
Christensen MM et al.
Pharmacogenetics and Genomics, 2013
Functional characterization of MATE2-K genetic variants and their effects on metformin pharmacokinetics.
Chung JY et al.
Pharmacogenetics and Genomics, 2013
A common 5'-UTR variant in MATE2-K is associated with poor response to metformin.
Choi JH et al.
Clinical Pharmacology and Therapeutics, 2011
Select a paper to view details